Coverage dated September 23, 2024

Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs

Headline from NBC 6 South Florida

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify Tuesday on Capitol Hill.

NBC 6 South Florida's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

26 articles, oldest first.

NBC 6 South Florida
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs (opens NBC 6 South Florida)
Published Sep 23, 2024
NBC 6 South Florida's feed description
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify Tuesday on Capitol Hill.
ABC 7 New York
Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug (opens ABC 7 New York)
Published Sep 23, 2024
ABC 7 New York's feed description
Senators grilled Novo Nordisk CEO Lars Jorgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs.
ABC 7 Chicago
'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing (opens ABC 7 Chicago)
Published Sep 23, 2024
ABC 7 Chicago's feed description
Senators grilled Novo Nordisk CEO Lars Jorgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs.
UPI
Ozempic drugmaker to testify on high drug prices before Senate committee (opens UPI)
Published Sep 23, 2024
UPI's feed description
The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy.
The Hill
Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices (opens The Hill)
Published Sep 23, 2024
The Hill's feed description
Despite pressure from Bernie Sanders, Novo Nordisk CEO Lars Fruergaard Jørgensen wouldn’t commit to lowering Ozempic and Wegovy prices during a Senate hearing Tuesday.
FOX Business
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs (opens FOX Business)
Published Sep 23, 2024
FOX Business's feed description
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Forbes
Novo Nordisk CEO Defends Ozempic Price In Senate Testimony (opens Forbes)
Published Sep 23, 2024
Forbes's feed description
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly prices exceeding $1,000 in the U.S.
Quartz
Novo Nordisk CEO blames drug 'middlemen' for high price of weight loss meds (opens Quartz)
Published Sep 23, 2024
Quartz's feed description
CEO Lars Fruergaard Jørgensen will appear before Congress on Tuesday to talk about the high prices of the company's popular Ozempic and Wegovy drugs
CBS News
Ozempic maker to testify before Senate committee on weight loss drug prices (opens CBS News)
Published Sep 23, 2024
CBS News's feed description
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.
Quartz
Novo Nordisk's CEO took the Washington hot seat over Ozempic prices. 3 takeaways from his testimony (opens Quartz)
Published Sep 23, 2024
Quartz's feed description
CEO Lars Fruergaard Jørgensen appeared before lawmakers Tuesday to talk about the company's popular weight-loss drugs

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.